29 completed, 13 unknown, 8 terminated, 6 recruiting. 58 Phase 2, 6 Phase 3, 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 58 | Completed 29, Unknown 13, Terminated 8, Recruiting 6, Withdrawn 2 |
| Phase 3 | 6 | Unknown 3, Recruiting 2, Completed 1 |
| Phase 1 | 5 | Completed 3, Terminated 1, Unknown 1 |
Follow Arthralgia: new trials by email Literature Review of Arthralgia trials Research Report on Arthralgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period Arumakimig, Placebo, Oral glucocorticoids - VEXAS Syndrome | Phase 2 | Recruiting | Novartis Pharmaceuticals | 120 | 2026-10-30 | 2026-11-09 |
| Pilot Study of Hydroxychloroquine for the Treatment of AIMSS Hydroxychloroquine Sulfate (HCQ) - Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain | Phase 2 | Recruiting | Indiana University | 35 | 2026-10-19 | 2026-11-10 |
| Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors Mindfulness Oriented Recovery Enhancement (MORE), Questionnaires, Supportive Psychotherapy (SG) - Breast Cancer Survivor | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 200 | 2024-12-06 | 2026-09-22 |
| Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1) Methotrexate - Arthritis, Arthralgia | Phase 2 | Terminated | AHS Cancer Control Alberta | 27 | 2024-08-12 | 2026-01-06 |
| The MUSE Study for Menopausal Arthralgia Menopausal hormone therapy, Exercise training, Menopausal hormone therapy + exercise training - Arthralgia, Menopause | Phase 2 / Phase 3 | Recruiting | National University Hospital, Singapore | 100 | 2024-08-01 | 2024-07-31 |
| Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis IHL-675A, Cannabidiol, Hydroxychloroquine - Rheumatoid Arthritis | Phase 2 | Terminated | Incannex Healthcare Ltd | 20 | 2023-11-22 | 2026-03-27 |
| Analysis of the Effect of Neuromuscular Electro-stimulation on the Performance of Isometric Rotator Cuff Strength. STRENGTH EVALUATION WITH ELECTROSTIMULATOR, STRENGTH EVALUATION WITHOUT ELECTROSTIMULATOR - Rotator Cuff Impingement Syndrome, Rotator Cuff Tendinitis | Phase 2 / Phase 3 | Unknown | University of Campinas, Brazil | 60 | 2023-09-01 | 2023-09-05 |
| Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Dapansutrile, Placebo Tablet - Acute Gout Flare, Gout Attack | Phase 2 / Phase 3 | Recruiting | Olatec Therapeutics, Inc. | 300 | 2023-01-06 | 2026-03-11 |
| An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection Zanamivir - Influenza, Human, Arthralgia | Phase 2 | Completed | GlaxoSmithKline | 8 | 2022-11-21 | 2026-07-28 |
| Clinical Efficacy of Exosome in Degenerative Meniscal Injury SF-MSC-EX, SF-MSC - Knee; Injury, Meniscus (Lateral) (Medial), Meniscus Tear | Phase 2 | Unknown | Eskisehir Osmangazi University | 30 | 2022-03-01 | 2022-03-04 |
| Comparison Between Retrolaminar and Medial Branch Block in Cervical Facet Joint Arthropathy Retrolaminar block, Medial Branch Block - Joint Pain | Phase 2 | Completed | Mansoura University | 70 | 2021-12-01 | 2024-03-04 |
| Immune-Mediated Pathophysiology And Clinical Triage Program Hydroxychloroquine, Placebo - Arthritis, Arthralgia | Phase 2 | Recruiting | AHS Cancer Control Alberta | 46 | 2021-09-16 | 2026-10-28 |
| A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee Osteoarthritis (OA) canakinumab, LNA043, Placebo to canakinumab - Knee Osteoarthritis | Phase 2 | Terminated | Novartis Pharmaceuticals | 23 | 2021-08-27 | 2025-10-24 |
| Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias Cannabidiol (CBD) - Arthralgia, Breast Cancer | Phase 2 | Completed | University of Michigan Rogel Cancer Center | 40 | 2021-04-16 | 2025-05-09 |
| Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN) Hesperidin, Placebo - Covid19, Anosmia | Phase 2 | Completed | Montreal Heart Institute | 216 | 2021-02-18 | 2022-04-08 |
| Efficacy of Sodium Thiosulfate in Shoulder Pain in Calcific Tendinitis of the Rotator Cuff Sodium Thiosulfate - Sodium Thiosulfate, Calcific Tendinitis | Phase 2 | Unknown | Soraia Azevedo | 80 | 2020-01-01 | 2021-09-28 |
| Effect of Intravenous Dexmedetomidine on Patient Discomfort in Laparoscopic Cholecystectomy Under Spinal Anesthesia. Dexmedetomidine, normal saline - Shoulder Pain | Phase 2 / Phase 3 | Unknown | Theodor Bilharz Research Institute | 40 | 2019-11-15 | 2021-04-02 |
| Efficacy of Erector Spinae Plane Block Versus Infraclavicular Subomohyoid Block in Shoulder Surgery Erector spinae block, Infraclavicular subomohyoid (ISO) block - Postoperative Pain, Shoulder Pain | Phase 1 / Phase 2 | Unknown | Ain Shams University | 80 | 2019-08-15 | 2020-12-16 |
| Resveratrol Trial for Relief of Pain in Pseudoachondroplasia resveratrol, Placebo - Pseudoachondroplasia | Phase 2 | Terminated | The University of Texas Health Science Center, Houston | 6 | 2019-06-29 | 2022-12-09 |
| Ultrasound-Guided Treatments for Shoulder Pain in Wheelchair Users With Spinal Cord Injury Lipogems, Dexamethasone - Spinal Cord Injuries, Tendinopathy | Phase 2 | Unknown | Kessler Foundation | 24 | 2019-06-14 | 2022-10-14 |
Showing 20 of 58. Sign in to see all of them.
Shoulder Pain (22) · Arthritis (9) · Pain (8) · Breast Neoplasms (7) · Myalgia (5) · Osteoarthritis (5) · Arthritis, Rheumatoid (3) · Motor Activity (3) · Osteoarthritis, Knee (3) · Shoulder Impingement Syndrome (3) · Headache (2) · Hemiplegia (2) · Inflammation (2) · Neck Pain (2)
Musculoskeletal Diseases (58) · Neurologic Manifestations (58) · Pathological Conditions, Signs and Symptoms (58) · Signs and Symptoms (58) · Joint Diseases (57) · Pain (50) · Skin and Connective Tissue Diseases (11) · Nervous System Diseases (10) · Rheumatic Diseases (9) · Skin Diseases (8) · Breast Diseases (7) · Neoplasms by Site (7) · Pathologic Processes (7) · Muscular Diseases (6)
Hydroxychloroquine (3) · Lidocaine (3) · Triamcinolone Acetonide (3) · Cannabidiol (2) · Cholecalciferol (2) · Dexmedetomidine (2) · Exercise (2) · High-Energy Shock Waves (2) · Saline Solution (2) · fulranumab (2) · Acupressure (1) · Acupuncture Therapy (1) · Adrenal Cortex Hormones (1) · Aromatase Inhibitors (1) · Blood Specimen Collection (1)
AHS Cancer Control Alberta (2) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Novartis Pharmaceuticals (2) · University of Colorado, Denver (2) · Ain Shams University (1) · Amgen (1) · Baylor Breast Care Center (1) · British Columbia Cancer Agency (1) · Centocor, Inc. (1) · Chiang Mai University (1) · Chulalongkorn University (1) · Dawn L. Hershman (1) · Duke University (1) · Endo USA Inc., a Keenova Therapeutics Company (1) · Erin Newton (1)
United States (24) · Canada (9) · Spain (5) · Egypt (4) · Australia (3) · Poland (3) · Italy (2) · Thailand (2) · Brazil (1) · China (1) · Czechia (1) · Denmark (1) · Estonia (1) · France (1) · Germany (1)
Michael Kolinsky (2) · Alejandro Arce-Salinas, M.D. (1) · Alice C. Shapiro, PhD RD (1) · Angela R Tate, PhD, PT (1) · Antonio I Cuesta-Vargas, PhD (1) · Carlos Molina-Calzada, M.D. (1) · Carme Casajuana, PT (1) · David Crowley, MD (1) · Dawn Hershman, MD (1) · Erin Newton, MD (1)
PMID 18383539, PMID 19959652, PMID 20599053, PMID 20710088, PMID 26051846, PMID 26286707, PMID 26795764, PMID 26868123, PMID 26894485, PMID 27238963, PMID 27477473, PMID 27748055, PMID 28257617, PMID 28388892, PMID 29890985, PMID 34067240, PMID 35005781, PMID 35604152, PMID 36300352, PMID 40751295
2009 (2), 2023 (1), K24HD054600 (1), R01AR055899 (1)